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Abstract
Purpose:  Screening  for  cardiac  iron  overload  is  generally  done  by  magnetic  resonance  imaging
(MRI) and  demonstrated  by  a  shortening  of  the  myocardial  T2*  below  20  ms  at  1.5  Tesla.  This
measurement  was  validated  with  a  speciﬁc  sequence  and  the  CMRTools® calculation  software
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(reference  technique).  The  objective  of  this  study  was  to  validate  the  use  of  sequences  and
software programs  that  are  available  in  routine  clinical  practice  to  screen  for  iron  overload.
Material  and  methods:  First,  a  phantom  of  11  tubes  with  a  T2*  between  4  and  33  ms  was  tested
at three  sites  that  had  MRI  machines  of  different  brands.  Second,  the  myocardial  T2*  values
of 75  patients  were  measured  in  routine  clinical  practice  using  two  methods.  The  ﬁrst  method
used the  reference  sequence  specially  installed  in  the  machines  associated  with  the  CMRTool
software.  The  second  method  used  the  standard  acquisition  sequences  available  in  the  machines
followed by  calculation  on  a  computer  spreadsheet.
Results:  In  the  phantom,  the  mean  of  the  differences  in  T2*  between  each  machine  was  0.6  ms.
Thirteen patients  had  a  lowered  T2*  value  with  the  reference  technique.  Three  cases  were
poorly classiﬁed  using  the  routine  technique  and  corresponded  with  false  positives  of  low
overload (T2*  between  18  and  20  ms).
Conclusion:  Screening  for  myocardial  iron  overload  can  be  done  by  MRI  by  using  sequences  and
calculation  software  available  in  routine  clinical  practice  during  the  same  examination  as  the
one for  the  evaluation  of  hepatic  iron  overload.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
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many  diseases  can  cause  iron  overload.  The  liver  is
lways  the  main  storage  organ.  However,  in  case  of  post-
ransfusion  overload  (such  as  constitutional  anemia  or  low
isk  myelodysplasia),  the  main  cause  of  death  induced  by
xcess  iron  is  myocardial  overload  [1].  For  all  of  these
iseases  treated  in  the  long-term  by  transfusions,  the  imple-
entation  of  oral  or  injectable  chelating  agents  is  necessary.
epatic  iron  concentrations  estimated  by  biopsy  or  MRI  as
ell  as  serum  ferritin  concentrations  do  not  directly  reﬂect
epatic  iron  overload  [2].  It  is  therefore  critical  to  be  able
o  screen  for  a  possible  myocardial  iron  overload,  which
equires  the  chelating  agent  to  be  intensiﬁed  and  adjusted
efore  irreversible  heart  failure  sets  in,  which  is  often
rreversible.
Excess  iron  in  the  tissues  induces  a  signiﬁcant  collapse  of
he  signal  due  to  changes  in  their  magnetic  susceptibility,
ausing  a  shortening  of  the  T2*  time  constant.  The  mea-
urement  of  hepatic  iron  concentrations  by  MRI  is  commonly
arried  out  in  routine  clinical  practice  [3,4].
Currently,  there  is  no  MRI  technique  that  allows  the
recise  measurement  of  myocardial  iron  concentrations.
owever,  it  has  been  established  that  the  minimum  nomi-
al  value  of  the  myocardial  T2*  is  20  ms  at  1.5  T  for  about
 dozen  years  [5].  Iron  overload  induces  a  shortening  of
he  T2*  below  this  value.  The  short-term  risk  of  heart
ailure  secondary  to  iron  overload  appears  for  T2*  values
f  less  than  10  ms  [6].  Several  teams  have  validated  the
eproducibility  of  this  measurement  by  using  strictly  iden-
ical  sequences  [7]  and  the  same  speciﬁc  post-treatment
oftware  program  (CMRTools®;  Cardio-vascular  Imaging  Solu-
ions,  London,  UK,  http://www.cmrtools.com)  [8]. Under
hese  conditions,  cardiac  MRI  is  an  important  detection  tech-
ique  for  myocardial  iron  overload  in  at  risk  patients.  The
rench  National  Authority  for  Health  recommends  an  MRI
very  1  or  2  years  for  patients  with  thalassemia  [9].
The  existence  of  various  MRI  machines  makes  it  difﬁcult
o  use  an  identical  sequence  at  all  of  the  sites.  In  addition,
ost  of  the  centers  do  not  have  the  speciﬁc  commercial
alculation  software  for  myocardial  T2*.
All  of  the  MRI  machines  currently  have  multi-echo  gradi-
nt  echo  sequences.  With  these  sequences,  it  is  therefore
b
c
pheoretically  possible  to  measure  the  T2*  time  constant,
ither  using  a  software  program  integrated  into  the  machine
r  by  simple  calculation.
The  objective  of  this  study  was  therefore  to  study  the
eproducibility  of  myocardial  T2*  measurements  obtained
n  routine  clinical  practice  for  the  detection  of  cardiac  iron
verload  (T2*  <  20  ms)  in  standard  machines  at  1.5  T,  with-
ut  an  additional  commercial  software  program.  The  ﬁrst
hase  consisted  of  the  phantom  study  of  the  correlation
f  the  measurements  obtained  using  imaging  machines  of
ifferent  brands  at  1.5  T,  with  the  standard  software  pro-
rams  and  sequences  available.  The  second  phase  consisted
f  comparing  the  T2*  values  obtained  using  two  methods
n  patients  at  risk  for  myocardial  iron  overload.  The  ﬁrst
ethod  used  the  reference  sequence  described  by  Ander-
on  et  al.  [5],  specially  implanted  in  the  machines,  followed
y  the  calculation  with  the  CMRTool® software  program.  The
econd  method  used  the  acquisition  sequences  available  in
tandard  practice  in  the  machines  followed  by  calculation
ith  a  spreadsheet.  Hepatic  iron  concentrations  were  mea-
ured  during  the  same  MRI  examination.
aterial and methods
hantom study
o  compare  the  T2*  measurements  between  several  imag-
ng  machines,  it  was  necessary  to  carry  out  a  phantom  study
ncluding  several  tubes  with  different  T2*  values,  close  to
he  heart  values  observed  in  clinical  practice.  Eleven  tubes
ere  thus  prepared  containing  an  agarose  gel  with  a  vari-
ble  concentration  of  ferucarbotran  (Cliavist,  Bayer-Shering
harma,  Loos,  France).  The  different  concentration  val-
es  were  calculated  using  the  transverse  relaxivity  of  the
garose  estimated  to  be  30  s−1 and  of  the  ferucarbotran  esti-
ated  to  be  82  mmol/s,  to  obtain  the  calculated  T2*  values
etween  4  and  33  ms,  respectively.
The  T2*  value  of  each  tube  was  then  measured  at  three
linical  sites  using  the  sequences  used  in  routine  clinical
ractice,  on  three  1.5  T  machines  of  different  brands  (MRI1:
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aCardiac  iron  overload:  MRI  screening  in  routine  clinical  prac
Intera  Philips,  Best,  Netherlands/MRI2:  Discovery  MR450
General  Electric,  Milwaukee,  WI,  USA/MRI3:  Magnetom  Sym-
phony  Tim  Siemens,  Erlangen,  Germany).  The  sequences
are  described  in  Table  1.  On  the  MRI1,  three  sequences,
including  two  echoes  were  used.  The  ﬁrst  versions  of  this
machine  only  allowed  two  echoes  to  be  used.  For  the  three
sequences,  the  value  of  the  ﬁrst  echo  time  was  unchanged
(2.5  ms)  and  the  signal  of  each  echo  was  standardized  on
the  signal  of  the  ﬁrst  echo  by  calculating  the  ratio  of  each
value  (considered  echo  signal/ﬁrst  echo  signal).  Thanks  to
this  standardization,  the  value  of  the  signal  of  the  ﬁrst  echo
(2.5  ms)  was  1  for  each  acquisition  and  the  value  of  the  sig-
nal  of  the  second  echo  was  the  percentage  of  the  signal
compared  to  the  ﬁrst  echo.  This  standardization  thus  made
it  possible  to  obtain  the  equivalent  of  one  sequence  with
four  echoes,  by  using  three  sequences,  which  only  had  two
echoes.
In  the  three  machines,  the  signal  of  each  tube  was  noted
individually  for  each  of  the  acquired  echoes.
At  the  site  of  the  MRI1,  the  T2*  values  were  calculated
using  the  formula  y  =  K  e-TE/T2∗.
where  y  is  the  intensity  of  the  signal,  K  is  a  con-
stant  and  TE  is  the  echo  time.  The  T2*  in  ms  is  then
obtained  by  adjusting  an  exponentially  decreasing  curve
using  the  spreadsheet  function  of  the  free  software  pro-
gram  Openofﬁce.org  (http://www.openofﬁce.org)  using  the
LOGREG  function.  This  function  calculates  the  adjustment
of  the  data  entered  in  the  form  of  an  exponential  regression
curve (y  =  b  ∗  mx)
At  the  MRI2  and  MRI3  sites,  the  T2*  was  calculated
directly  by  the  software  program  included  in  the  machine.
Study in the patients
The  data  of  75  patients  who  had  a  cardiac  MRI  to  screen  for
post-transfusion  iron  overload  between  May  2009  and  May
2011  were  included  in  this  study  retrospectively.
The  median  age  of  the  patients  was  36  years
(11—88  years).  All  of  the  patients  were  transfused  reg-
ularly  and  received  more  than  20  units  of  red  blood  cell
concentrates.
These  patients  had  major  thalassemia  (n  =  36),  sickle-
cell  anemia  (n  =  10),  intermediate  thalassemia  (n  =  6),
myelodysplastic  syndrome  (n  =  9),  acute  leukemia  (n  =  7),
aplastic  anemia  (n  =  3),  pyruvate  kinase  deﬁciency  (n  =  2),
Blackfan—Diamond  disease  (n  =  1)  and  congenital  dysery-
thropoietic  anemia  (n  =  1).
The  examinations  were  carried  out  in  two  different  cen-
ters  by  two  different  medical  teams,  but  on  the  same  model
of  machine,  Intera  Philips  (Best,  Netherlands).  For  each
patient,  the  cardiac  T2*  was  measured  according  to  two
procedures.
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Table  1  Parameters  of  the  sequences  used  for  the  study  of  th
MRI13  sequences  2  echoes  MRI
TE  (ms)  2.5—5  /  2.5—10  /  2.5—20  2.1
TR  (ms)  8  /  13  /  23  23.
Angle  (degree)  20  20  603
For  the  ﬁrst  procedure,  three  gradient-echo  sequences
t  two  echoes  identical  to  the  one  described  for  MRI1  for
he  phantom  study  were  used.  The  angle  was  20◦ for  the
hree  sequences  with  the  following  repetition  time  (TR)  and
cho  time  (TE):  TR  =  23  ms,  TE  =  2.5—20  ms/TR  =  13  ms,
E  = 2.5—10  ms/TR  =  8  ms,  TE  =  2.5—5  ms.  The  three
equences  allowed  the  equivalent  of  a  sequence  with
our  echo  times  (2.5,  5,  10  and  20  ms)  to  be  obtained.
he  second  procedure,  the  reference  technique,  used  the
equence  described  by  Anderson  et  al.  [5].  The  parameters
f  this  sequence,  installed  at  each  site  by  a  Philips  study
ngineer,  were  as  follows:  nine  echoes  of  5.6  to  17  ms,
R  =  19.3  ms,  angle  35◦.  The  signal  was  acquired  in  the
inor  axis  of  the  heart  with  synchronization  by  a  pulse
ensor.  The  examinations  were  performed  with  patients
ho  were  holding  their  breath.
The  technique  with  the  three  bi-echo  sequences  in
ombination  with  the  calculation  of  the  T2*  using  a  spread-
heet,  which  is  called  the  tested  technique.  The  reference
equence  combined  with  the  calculation  by  the  CMRTools®
oftware  program  is  called  the  reference  technique.
The  T2*  calculations  were  carried  out  on  a  blind  basis  at
he  end  of  the  study  in  a  different  way  for  each  sequence.
For  the  ﬁrst  procedure,  the  signal  of  the  inter-ventricular
eptum  was  picked  up  in  the  same  ovular  region  of  interest
or  each  echo.  The  signal  of  each  echo  was  standardized
ased  on  that  of  the  ﬁrst  echo  and  afterwards  the  T2*  was
hen  calculated  with  the  openofﬁce.org  software  program.
or  the  second  procedure,  the  T2*  was  calculated  with  the
MRTools®  software  program.
Hepatic  iron  concentrations  measured  during  the  same
RI  examination  and  serum  ferritin  values  were  noted  for
ach  patient.
tatistic study
ll  of  the  data  were  analyzed  with  the  PASW  Statistics  soft-
are  program  (Version  17.0,  SPSS  Inc,  Chicago,  IL,  USA).
For  the  phantom  study,  the  coefﬁcient  of  variation
etween  each  measurement  and  the  mean  value  was  calcu-
ated  using  the  standard  deviation  of  the  half-square  of  the
ean  value  of  the  differences.  The  coefﬁcient  of  variation  is
xpressed  as  a percentage.  The  intraclass  correlation  coef-
cient  (ICC)  was  also  calculated.  ICC  values,  greater  than
.90,  were  considered  to  be  excellent.
For  the  study  in  patients,  the  speciﬁcity,  sensitivity  and
ositive  and  negative  predictive  values  for  the  detection  of
 shortening  of  the  myocardial  T2*  were  calculated  com-
ared  to  the  results  obtained  with  the  reference  technique.
he  agreement  between  the  two  methods  was  obtained
y  Bland—Altman  analysis.  The  agreement  between  the
yocardial  T2*  values  depending  on  the  two  techniques  and
e  phantom  (1.5  T).
21  sequence  8  echoes  MRI31  sequence  12  echoes
—21.3  12  echoes:  2.1—25.3
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epatic  iron  concentrations  and  serum  ferritin  levels  was
tudied  using  the  Pearson  correlation  coefﬁcient.
esults
hantom study
he  T2*  values  measured  in  the  11  tubes  are  between  a  min-
mum  of  3.28  ms  and  a  maximum  of  33.15  ms  (Fig.  1).  The
esults  obtained  with  the  different  ones  were  very  close.
he  coefﬁcients  of  variation  between  the  three  machines
ere  5.3%,  6.4%  and  6.7%,  respectively.  The  mean  value  of
he  differences  between  each  machine  was  0.6  ms.  The  ICC
alue  was  excellent  (ICC  >  0.99).
atient study
he  mean  myocardial  T2*  was  measured  at  28  ms  (5  to  57  ms)
or  the  tested  technique  and  32  ms  (10  to  59  ms)  for  the  ref-
rence  technique  (Figs.  2  and  3).  The  T2*  values  calculated
or  each  method  are  presented  in  Fig.  4.  For  the  detec-
ion  of  the  shortening  of  less  than  20  ms  of  the  myocardial
2*,  the  tested  technique  had  a  sensitivity  of  100%  (0.95
I  =  71.7—100),  a  speciﬁcity  of  94.6%  (0.95  CI  =  85.6—98.7),
 positive  predictive  value  of  81.2%  (0.95  CI  =  53.7—95)  and  a
egative  predictive  value  of  100%  (0.95  CI  =  92.4—100)  com-
ared  to  the  reference  technique.Sixteen  patients  had  a  T2*  of  less  than  20  ms  with  the
ested  technique  vs  thirteen  with  the  reference  technique.
or  the  three  discordant  patients,  the  T2*  values  were  mea-
ured  with  the  multi-echoes  sequence  and  the  sequence  of
f
s
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igure 1. Comparison of the T2* values calculated independently for
black, hatching, gray).O.  Ernst  et  al.
he  Brompton  Hospital  at  18  vs  20  ms,  18  vs  21.2  ms  and
9.84  vs  30.2  ms,  respectively.
For  all  of  the  patients,  the  mean  of  the  T2*  differences
nd  the  standard  deviation  of  the  T2*  differences  between
he  two  techniques  were  −4.07  ms  and  10.45  ms,  respec-
ively,  as  per  the  Bland—Altman  method.  For  T2*  values  of
ess  than  20  ms,  these  values  were  0.28  ms  and  3.14  ms,
espectively.
The  mean  serum  ferritin  levels  were  866  ng/mL
35—5574)  and  the  mean  hepatic  iron  concentrations  were
15  mol/g  (10—830).  There  was  no  correlation  between
he  myocardial  T2*  value  and  hepatic  iron  concentra-
ions  (R  =  0.13,  P  =  0.26)  or  serum  ferritin  levels  (R  =  0.11,
 =  0.36).
iscussion
he  vital  prognosis  of  the  patients  with  post-transfusion  iron
verload  is  mainly  related  to  cardiac  overload  [1].  There-
ore,  MRI  monitoring  of  myocardial  overload  via  the  T2*
as  become  an  essential  screening  and  monitoring  tool  for
helating  treatments.  It  has  been  established  that  these
reatments  signiﬁcantly  reduce  the  morbidity  and  mortal-
ty  of  these  patients  by  improving  their  cardiac  prognosis
10].
In  these  patients,  the  regular  dosage  of  serum  ferritin
evels  is  still  the  most  commonly  used  piece  of  information
or  the  evaluation  of  the  degree  of  iron  overload  [11].  A
igniﬁcant  correlation  between  the  assay  of  serum  ferritin
oncentrations  and  intrahepatic  iron  concentrations  has
een  reported  in  several  studies  [11,12].  On  the  other  hand,
 11 tubes with a decreasing T2* value by three different centers
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Figure 2. Patient with signiﬁcant hepatic iron overload at 15 times the normal value and an absence of myocardial overload (T2* = 44 ms).
The images to the left correspond to an acquisition with an echo time of 2.5 ms,  and the images to the right of 5/10/20 ms, from the top to
the bottom. While the signal of the liver and spleen decrease considerably starting at 5 ms of TE, the signal of the heart only shows a very
small decrease.
606  O.  Ernst  et  al.
Figure 3. Patient with a signiﬁcant hepatic iron overload at seven times the norm and a clear myocardial overload (T2* = 10.2 ms). The
images to the left correspond to an acquisition with an echo time of 2.5 ms, and the images to the right of 5/10/20 ms, from the top to the
bottom. While the signal of the liver and spleen decrease considerably starting at 5 ms of TE, the signal of the heart only shows a very small
decrease. The signal of the liver and spleen decrease considerably starting at 5 ms of TE, and the signal of the inter-ventricular septum
of the heart disappears almost completely at 20 ms, which demonstrates a clear shortening of the myocardial T2* characteristic of an iron
overload.
Cardiac  iron  overload:  MRI  screening  in  routine  clinical  practice  
Figure 4. Graph comparing the myocardial T2* values of 75
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the  errors  only  concerned  small  reductions  in  T2*  that  dopatients obtained using the reference method and the technique
available in routine clinical practice.
as  it  has  been  described  in  the  literature  [13,14],  our  study
did  not  demonstrate  a  signiﬁcant  correlation  between  the
myocardial  T2*  and  serum  ferritin  levels  as  with  intrahepatic
iron  concentrations.  Serum  ferritin  levels  and  intrahepatic
iron  concentrations  are  therefore  not  very  predictive  of  a
cardiac  iron  overload  [2].
Cardiac  MRI  with  T2*  measurement  has  been  shown  to
be  a  sensitive,  non-invasive  and  reproducible  method  in
the  evaluation  and  monitoring  of  myocardial  iron  overload,
then  for  the  prevention  of  cardiac  complications  related  to
this  overload  [1].  The  carrying  out  of  myocardial  biopsies  in
routine  clinical  practice  is  not  very  realistic.  There  is  only
one  study  of  12  cases  comparing  at  1.5  T  the  myocardial
T2*  value  to  cardiac  iron  concentrations  [15].  Therefore,
only  a  T2*  value  can  be  given,  contrary  to  the  case  of  the
liver,  where  a  veritable  iron  concentration  can  be  measured
thanks  to  calibration  curves  established  using  liver  biopsies
[3,4].
Since  the  ﬁrst  publication  of  the  importance  of  the  mea-
surement  of  T2*  in  thalassemia  [5],  the  technique  has  been
validated  in  routine  clinical  practice.  It  has  been  shown
that  the  method  is  indeed  reproducible,  by  using  the  same
sequence  and  the  same  calculation  software  program  [8].
The  objective  of  our  study  was  therefore  to  validate  those
similar  results  could  be  obtained  with  different  machines,
different  sequences  and  different  calculation  software  pro-
grams.
Our  phantom  study  allowed  us  to  demonstrate  an  excel-
lent  correlation  between  the  measurements  of  T2*  on
different  machines  and  according  to  different  sequences  and
calculation  methods  used  in  routine  clinical  practice.  The
calculation  of  T2*  values  is  therefore  indeed  reproducible,
in  vitro,  on  standard  clinical  machines  of  the  same  magnetic
ﬁeld  intensity  by  using  the  sequences  and  the  calculation
software  programs  available.  A  recent  study  also  showed
that  the  T2*  calculation  results  were  not  dependent  on  the
software  program  used  [16].The  sequences  used  for  the  T2*  calculation  in  patients
of  course  had  to  be  modiﬁed  in  relation  to  the  sequences
used  in  the  phantom.  A  different  geometry  and  the  need  to
n
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se  cardiac  synchronization  must  be  taken  into  account.  A
linical  study  was  therefore  absolutely  necessary  to  conﬁrm
he  experimental  results.
The  purpose  of  our  clinical  study  was  therefore  to  vali-
ate  the  possibility  of  using  MRI  sequences  and  the  software
rograms  that  are  available  in  routine  clinical  practice  to
creen  for  the  shortening  of  the  myocardial  T2*,  which
roves  that  there  is  iron  overload.  In  our  series,  we  obtained
xcellent  sensitivity  values,  speciﬁcity  values,  positive  pre-
ictive  value  and  negative  predictive  value  for  the  detection
f  T2*  of  less  than  20  ms  compared  to  the  reference  tech-
ique.  Three  patients  out  of  75,  however,  had  a  result  that
as  different  between  the  two  techniques.  Two  patients  had
 T2*  measured  at  18  ms  with  the  tested  technique  for  20  and
1.2  ms,  respectively,  with  the  reference  technique.  The
hird  patient  had  a  T2*  measured  at  19.8  ms  for  a  measure-
ent  of  30.2  ms  with  the  reference  method.  These  errors
herefore  only  concern  results  close  to  20  ms.
The  Bland—Altman  analysis  shows  that  the  T2*  mea-
urement  error,  compared  to  the  reference  technique,  is
learly  higher  for  values  above  20  ms  (standard  deviation  of
0.45  ms)  than  for  values  lower  than  20  ms  (standard  devi-
tion  of  3.14  ms).  This  is  explained  by  the  value  of  20  ms
sed  for  the  longest  echo.  This  value  corresponds  to  a  63%
eduction  in  the  free  precession  signal  for  a  T2*  of  20  ms,
hich  is  sufﬁciently  signiﬁcant  to  minimize  the  effect  of  the
oise.  For  longer  T2*  values,  the  drop  in  the  signal  is  lower
nd  the  relative  effect  of  the  noise  increases.  The  measure-
ent  therefore  becomes  very  imprecise.  It  is  not  possible
o  reliably  estimate  T2*  values  that  are  clearly  greater  than
he  longest  TE  [17].  Regardless  of  whether  it  is  for  the  refer-
nce  technique  or  the  tested  technique,  the  sequences  were
ot  optimized  to  measure  T2*  values  greater  than  20  ms,  as
he  objective  was  to  detect  an  abnormal  shortening  below
0  ms,  which  remains  the  clinical  objective.
The  study  in  the  phantom  and  in  the  patients  shows  that
he  measurement  of  the  shortening  of  the  cardiac  T2*  is  a
easurement  that  can  be  reproduced  using  different  mul-
iple  gradient  echo  sequences  and  different  T2*  calculation
oftware  programs.  However,  the  value  of  the  magnetic  ﬁeld
ust  be  identical,  as  the  T2*  values  depend  on  the  inten-
ity  of  the  magnetic  ﬁeld.  To  appreciate  a shortening  of  less
han  20  ms  of  the  T2*,  the  longest  echo  must  be  at  least
0  ms.
Currently,  multiple  gradient  echo  acquisitions  are  rou-
inely  available  from  all  manufacturers.  As  all  of  the  echoes
re  acquired  during  the  same  sequence,  these  multiple  echo
cquisitions  are  preferable  to  multiple  sequences  that  only
ave  two  echoes.
The  main  limitation  of  the  tested  method  is  the  impre-
ision  of  the  measurement,  which,  in  our  study,  led  to  a
iagnostic  error  in  three  out  of  75  patients.  This  impreci-
ion,  which  is  clearly  greater  than  in  the  phantom  study,
s  probably  due  to  the  multiple  artefacts  encountered  in
linical  practice,  particularly,  artefacts  due  to  respiratory
ovements.  However,  all  the  T2*  values  of  less  than  18  ms
ith  the  tested  technique  corresponded  to  a shortening  of
ess  than  20  ms  with  the  reference  technique.  Therefore,ot  have  a direct  clinical  impact  in  the  short-term,  as  the
isk  of  heart  failure  generally  occurs  below  the  threshold  of
0  ms  [6]. In  case  of  routine  use  in  clinical  practice  of  the
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ested  technique,  small  shortenings  of  the  T2*  therefore  do
ot  make  it  possible  to  diagnose  iron  overload  with  certainty.
t  can  therefore  be  useful  to  carry  out  a  remote  control
xamination.
onclusion
n  conclusion,  the  screening  for  a  myocardial  T2*  shorten-
ng  can  be  carried  out  in  clinical  practice  with  the  standard
equences  available  on  MRI  machines.  The  T2*  can  be  cal-
ulated  with  the  software  programs  of  the  manufacturer
f  the  machine  or  on  a  simple  spreadsheet.  As  serum  fer-
itin  levels,  hepatic  iron  concentrations  and  myocardial  iron
oncentrations  reﬂect  different  storage  compartments,  it
s  important  to  monitor  these  three  parameters  [11].  Dur-
ng  an  MRI  exam  to  monitor  iron  overload  of  hematological
rigin,  we  are  therefore  conducting  at  the  same  time  the
alculation  of  hepatic  iron  concentrations  and  the  calcula-
ion  of  the  myocardial  T2*,  as  these  2  measurements  were
ecommended  by  the  French  National  Authority  for  Health
n  patients  with  thalassemia  [9].  We  also  associate  the  mea-
urement  of  the  ventricular  ejection  fraction.  In  one  single
xamination,  the  MRI  thus  makes  it  possible  to  measure  sev-
ral  absolutely  necessary  parameters  for  the  monitoring  of
hronic  post-transfusion  iron  overload.
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